Evidence map›Paper›PMID 40394818›Full record

ArticleAnnals of occupational and environmental medicine2025

Occupational disease issues in high-tech industries of South Korea: analysis of governmental data on the semiconductor and display industries.

Chungsik Yoon, Jinjoo Chung, Jongran Lee, Kwonchul Ha, Joseph DiGangi, Jeong-Ok Kong

Abstract read
In one paragraph

Article in Annals of occupational and environmental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chungsik YoonDepartment of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Korea.
Jinjoo ChungKorea Workers' Compensation & Welfare Service, Seoul, Korea.
Jongran LeeSupporters for the Health and Rights of People in the Semiconductor Industry (SHARPS), Seoul, Korea.
Kwonchul HaDepartment of Biochemistry & Health Science, Changwon National University, Changwon, Korea.
Joseph DiGangiInternational Pollutants Elimination Network (IPEN), Gothenburg, Sweden.
Jeong-Ok KongWorkers Health Center in East Gyeonggi Province, Seongnam, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study analyzed occupational diseases compensated through the government system in the Korean electronics industry and observed changes in the rationale for compensation.

methodsData from the Korea Workers' Compensation and Welfare Service (KWCWS) from 2012 to 2023 were analyzed to examine occupational disease issues in South Korea's semiconductor and display industries.

resultsKWCWS received 174 occupational disease claims between 2012 and 2023, with 88 (50.6%) approved. The case of a 22-year-old semiconductor worker who died from leukemia has raised awareness and appears to be leading to more claims and higher approval rates. Cancer-related claims, particularly for breast and blood cancers, were the most common. Since 2018, the approval rate for occupational diseases has increased to 60%, which may have been influenced by the Supreme Court's Principle of Presumption of Occupational Diseases and the government's reduction of the burden of proof. However, approval rates remain lower in small- and medium-sized enterprises (38.0%) compared to large corporations (55.6%), likely because of better documentation and unionization in the latter. The semiconductor industry had more claims and approvals than the LCD industry, primarily due to its longer operational history and greater chemical exposure.

conclusionsIn South Korea, the increasing approval rate of occupational diseases in the electronics industry from 2012 to 2023 appears to reflect changes in how causal relationships and occupational health policies have been implemented and this is likely due to stakeholder involvement and relevant legal decisions.

Identifiers

PMID40394818
PMCPMC12315778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.